NCT04948840View on ClinicalTrials.gov

Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Radiation ToxicityFibrosisBreast Cancer
Interventions
BIOLOGICAL

Blood sampling

Blood sample of 7 mL whole venous blood in an EDTA citrate tube (4.5 mL) and a PAXgene Blood RNA tube (2.5 mL).

Trial Locations (3)

4240

RECRUITING

Centre François Baclesse, Esch-sur-Alzette

Unknown

RECRUITING

Centre Hospitalier de Metz Thionville, Metz

RECRUITING

Institut de Cancérologie de Lorraine, Nancy

Sponsors

Collaborators (1)

Inotrem
All Listed Sponsors
collaborator

Inotrem

INDUSTRY

lead

Centre Francois Baclesse, Luxembourg

OTHER